Feb 01 2013 10 mins
Dr. Ramalingam answers questions on the changing landscape of cancer clinical trials and how new studies are being designed in the new era of molecular oncology.
Dr. Ramalingam answers questions on the changing landscape of cancer clinical trials and how new studies are being designed in the new era of molecular oncology.